Kyzatrex® Webinar
Restore Testosterone Levels with FDA-Approved KYZATREX®
Would you like to attend?
We're excited about the upcoming free webinar and hope that you can join us. Click below to secure your spot!
Kyzatrex® Webinar
PRESENTED BY: Dr. Mohit Khera
HOSTED BY: Kyle Vorndran of Empower
DATE: April 10, 2025
TIME: 6:30PM CST | 4:30PM PST
More About the Event:
Empower is thrilled to host an educational webinar on KYZATREX®, the FDA-approved oral testosterone treatment designed for men with low testosterone. It’s been shown to be up to 96% effective in helping men restore testosterone to normal levels.1,2* This informative session will give prescribers key insights into this innovative treatment option and how it can benefit their patients.
📅 When: Thursday, April 10, 2025 at 6:30PM CST
⏳ Duration: 60 minutes
📍 Sign up: Register here
In this engaging session, "Personalizing Testosterone Therapy: Exploring Oral Solutions," you’ll learn:
- The history and need for Testosterone Replacement Therapy (TRT)
- Benefits and clinical considerations of KYZATREX® as an oral testosterone replacement therapy.
- Discover how Empower can support your practice by providing compounded, brand-name, and generic medications all-in-one place.
- Our nationwide shipping capabilities, ensuring seamless patient access across all 50 states.
Meet Your Presenter:Dr. Mohit Khera, M.D., M.B.A., M.P.H., is a Professor of Urology at Baylor College of Medicine, specializing in male infertility and sexual dysfunction. He has authored numerous publications, co-edited Urology and the Primary Care Practitioner, and serves on the board of the Sexual Medicine Society of North America. Follow on Instagram.
DISCLAIMER: This information is intended for educational and informative purposes and not intended to serve as medical or business advice. All clinical questions on Empower products should be directed to an Empower clinical pharmacist or medical affairs specialist.
See Full Prescribing Information and Medication Guide for KYZATREX.
REFERENCES:
*In a six-month clinical trial of 139 men with low testosterone, 88% of patients had normal testosterone levels at Day 90 (worst-case scenario calculation, excluding Site 104). Based on patients who completed the study (n=127), 96% of patients achieved normal testosterone levels at Day 90.
- KYZATREX [prescribing information]. Raleigh, NC: Marius Pharmaceuticals; 2022.
- Data on file. Raleigh, NC: Marius Pharmaceuticals, 2020.